Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Velocity Pharmaceutical Development, LLC logo — company profile

Velocity Pharmaceutical Development, LLC

Founded 2011 United States South San Francisco, United States 2 employees Biotechnology, Pharmaceutical

General Information

Company Name Velocity Pharmaceutical Development, LLC
Founded Year 2011
Location United States South San Francisco, United States +1
Employees 2
Industries Biotechnology, Pharmaceutical
Social

Get notified when Velocity Pharmaceutical Development, LLC moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Velocity Pharmaceutical Development, LLC

VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates. VPD acquires rights to individual therapeutic drug candidates from biotechnology companies, pharmaceutical companies and academia, and invests in their development through clinical proof-of-concept (generally demonstration of human safety and efficacy in phase 2a trials). Following proof-of-concept, VPD seeks to sell each drug asset to a major pharmaceutical company. There is a robust demand by pharmaceutical acquirers for products with key human clinical data. Our model provides partners with a compelling alternative strategy for the development of their drug candidates. By partnering with VPD, the owner of a drug candidate can achieve the funding needed to take the drug candidate to clinical proof-of-concept while accessing a world-class team to design and oversee the development program. The contributor of the drug candidate receives equity in the company created to house its drug program and benefits from the ultimate financial upside upon clinical success and sale of that company to a pharmaceutical company. The Velocity model is much more efficient than traditional company-based drug development because it avoids the cost and time of building a separate management team and infrastructure around each program.

No funding data available for Velocity Pharmaceutical Development, LLC yet.

Get notified when Velocity Pharmaceutical Development, LLC raises funding

Velocity Pharmaceutical Development, LLC Alternatives & Competitors

Velocity Pharmaceutical Development, LLC vs
Cloudbreak Therapeutics
Cloudbreak Therapeutics

Leading the future of eye care with efficient drug repurposing and fast-tracked clinical advancement...

Series C
11-50 employees
Biotechnology, Health Care
Velocity Pharmaceutical Development, LLC vs
Idenix Pharmaceuticals
Idenix Pharmaceuticals

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a stron...

Post Ipo Equity
Biotechnology, Health Care
Velocity Pharmaceutical Development, LLC vs
P2D Bioscience
P2D Bioscience

P2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs th...

3 employees

FAQ About Velocity Pharmaceutical Development, LLC

VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates. VPD acquires rights to individual th...
Velocity Pharmaceutical Development, LLC was founded in 2011.
Velocity Pharmaceutical Development, LLC is headquartered in South San Francisco, United States.
Velocity Pharmaceutical Development, LLC operates in the following industries: Biotechnology, Pharmaceutical.
Velocity Pharmaceutical Development, LLC has approximately 2 employees.
Top alternatives and competitors to Velocity Pharmaceutical Development, LLC include Cloudbreak Therapeutics, Idenix Pharmaceuticals, P2D Bioscience, Bazell Pharma, High Point Clinical Trials Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Velocity Pharmaceutical Development, LLC and Cloudbreak Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Velocity Pharmaceutical Development, LLC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy